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The transmissible agent causing canine trans-
missible venereal tumor (CTVT) is thought to
be the tumor cell itself. To test this hypothesis,
we analyzed genetic markers including major
histocompatibility (MHC) genes, microsatellites,
and mitochondrial DNA (mtDNA) in naturally
occurring tumors and matched blood samples.
In each case, the tumor is genetically distinct
from its host. Moreover, tumors collected from
40 dogs in 5 continents are derived from a
single neoplastic clone that has diverged into
two subclades. Phylogenetic analyses indicate
that CTVT most likely originated from a wolf or
an East Asian breed of dog between 200 and
2500 years ago. Although CTVT is highly aneu-
ploid, it has a remarkably stable genotype. Dur-
ing progressive growth, CTVT downmodulates
MHC antigen expression. Our findings have im-
plications for understanding genome instability
in cancer, natural transplantation of allografts,
and the capacity of a somatic cell to evolve
into a transmissible parasite.
INTRODUCTION
CTVT, also known as Sticker’s sarcoma, is a histiocytic tu-
mor that is usually transmitted among dogs through coitus
but may also spread through licking, biting, and sniffing
tumor-affected areas (Cohen, 1985; Das and Das, 2000).
First characterized 130 years ago (Novinski, 1876), CTVT
was frequently used by cancer researchers to study tumor
transplantation until the development of inbred strains
of rats and mice afforded syngeneic models. The notion
that the tumor is naturally transmissible as an allograft
came from three lines of observation. First, CTVT can
only be experimentally induced by transplanting livingtumor cells, and not by killed cells or cell filtrates (Cohen,
1985). Second, the tumor karyotype is aneuploid but has
characteristic marker chromosomes in tumors collected
in different geographic regions (Murray et al., 1969; Oshi-
mura et al., 1973; Weber et al., 1965). Third, a long inter-
spersed nuclear element (LINE-1) insertion near c-myc
(Katzir et al., 1985) has been found in all tumors examined
so far (Katzir et al., 1987) and can be used as a diagnostic
marker to confirm that a tumor is CTVT (Liao et al., 2003).
In two animals that had been experimentally inoculated
with CTVT, the resulting tumors contained the LINE-1/
c-myc insertion, whereas the normal tissues did not (Katzir
et al., 1987; Liao et al., 2003). However, in natural trans-
mission, inheritance of a LINE-1 insertion near c-myc in
the germline might represent a predisposition to develop
CTVT after exposure to an oncogenic agent, similar to
the Mendelian LINE-1 insertion in the factor IX gene, which
causes mild hemophilia B in dogs (Brooks et al., 2003).
The recent emergence of a tumor transmitted by biting
in the endangered marsupial species the Tasmanian devil
(Sarcophilus harrisii) (Owen and Pemberton, 2006) has
attracted renewed interest in the concept of cellular trans-
mission, for which CTVT is cited as a precedent (Pearse
and Swift, 2006). However, authors of reports describing
virus-like particles in CTVT (Ajello and Gimbo, 1965; Bat-
tistacci and Morriconi, 1974; Lombard and Cabanie,
1967) considered that an oncogenic virus might play a
role in tumorigenesis. Although most specialists in the field
accept the cellular transmission of CTVT, definitive data
that this is the case have been lacking, and the concept
of a contagious cancer cell has tended to be greeted
with skepticism by many oncologists and immunologists.
Molecular genetic markers have not previously been
used to resolve the issue of natural transmission, the breed
of origin, or the age of the canine tumor. Here, we compare
matched tumor and normal tissues in naturally affected
dogs in three countries and analyze the genotype and di-
versity of further tumors collected worldwide. We provide
conclusive evidence that a cancer cell has evolved into a
transmissible parasite, which represents the oldest known
somatic mammalian cell in continuous propagation.Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc. 477
RESULTS
Clonal Origin of Worldwide Specimens of CTVT
Matched tumor tissues and blood samples were collected
from 16 unrelated dogs in Italy, India, and Kenya, and we
also examined microdissected tumor cells derived from
paraffin-embedded specimens obtained from 24 indepen-
dent natural tumors from Brazil, the United States, Turkey,
Spain, and Italy (Table 1). First we sought to confirm
whether the LINE-1 element near c-myc previously de-
tected in CTVT (Katzir et al., 1985) is specific to the tumor
cell or whether it represents a genetic predisposition to de-
velop CTVT after exposure to a transmissible agent. All of
the naturally occurring tumors but none of the matched
normal samples from 16 dogs possessed this LINE-1 inser-
tion, as shown for 11 tumors in Figure 1A. The tumor-spe-
cific LINE-1 insertion was present in all of the archival CTVT
samples (Figure 1B), as previously reported for tumors in
the United States, Israel, and Taiwan (Katzir et al., 1987;
Liao et al., 2003). Thus, the LINE-1 insertion appears to
be a specific marker of CTVT resulting from either an inser-
tion during the somatic evolution of the tumor or its pres-
ence in the germline of the original host. Germline insertion
at this locus has not been reported; however, it has not
been examined in the canine lineage from which the tumor
appears to be derived (see below). Even if the LINE-1 inser-
tion were in the germline, the chromosome pattern and the
molecular genetic analysis presented below indicate that
the tumor lineage itself is somatically monoclonal.
Next we analyzed the sequence of the most polymor-
phic genes (Kennedy et al., 2002b) of the canine MHC
(also known as dog leukocyte antigen [DLA]): the class I
gene (DLA-88 exons 2 and 3) and three class II genes
(exon 2 of DRB1, DQB1, and DQA1). Using generic intron
PCR primers followed by sequencing of the amplified
DLA alleles, we found that, in each case, the CTVT DLA
haplotype was different from those of the hosts but was
identical among tumors. We therefore designed PCR am-
plification primers for the DLA alleles that are tumor spe-
cific and confirmed that all of the tumors shared the
same alleles in all four DLA genes, which were not present
in matched normal tissue (Figure 1A). The tumor-specific
alleles were also detected in the paraffin-embedded
specimens collected worldwide (Figure 1B).
The DLA genotyping indicated that the class II genes in
CTVT are either homozygous or hemizygous, except for
the DRB1 gene, which possesses two alleles that differ
by one nonsynonymous substitution distant from the
peptide binding groove. Quantitative PCR was therefore
performed to determine DLA gene dosage. While the
DLA-88,DRA, andDRB1 genes were diploid in all samples
(data not shown), the DQB1 locus was haploid (hemizy-
gous) in 5 of 11 fresh tumors, and the DQA1 locus was
haploid in 12 of 29 tumors analyzed, indicating a frequent
loss of class IIDQ alleles (see Figure S1 in the Supplemen-
tal Data available with this article online).
Microsatellite genotyping was conducted by PCR am-
plification of 21 canine microsatellite markers that are478 Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc.widely dispersed across different chromosomes in the
normal karyotype (Parker et al., 2004). These were chosen
to compare tumor and normal DNA in 11 of the dogs from
which both types of tissue were available. A neighbor-join-
ing tree was constructed using chord distance (Figure 2),
which showed that the tumors and the hosts were genet-
ically separate, with all tumors clustered together. A
neighbor-joining tree based on the proportion of alleles
shared between pairs of samples gave a similar result (Fig-
ure S2). None of the host dogs showed close relatedness
to any of the others, consistent with the fact that they
came from three locations in Europe, Asia, and Africa
and were mongrels.
A further polymorphic marker analyzed was the mito-
chondrial DNA (mtDNA) control region. A 580 bp sequence
was amplified from 11 fresh specimens and compared to
the mtDNA of their hosts. In order to place our data in the
context of dog and wolf mtDNA sequences, we analyzed
our data in conjunction with sequences collected in previ-
ous studies of canids (Vila et al., 1997; Savolainen et al.,
2002). All of the tumor sequences grouped together into
two distinct clusters (Figure S3), both of which lie within
clade A of the canine mtDNA tree; this clade includes
70% of all dog mtDNA sequences (Savolainen et al.,
2002). In contrast, the sequences from the mtDNA from
the blood of host dogs bearing the tumor were scattered
across clades A, B, and C. Although sequence variation
in the mtDNA control region can arise by somatic mutation
in human tumors (Vega et al., 2004), the lack of genetic
relatedness between matched normal and CTVT mtDNA
haplotypes, and the genetic clustering of the tumors, con-
firmed that the tumors in the dogs from Italy, India, and
Kenya were distinct from their hosts.
A shorter 257 bp amplified fragment of mtDNA
was analyzed in 21 microdissected tumor cells from
Table 1. Sources of CTVT Samples














Details of age, sex, breed of dog, and site of tumor are in Table S1.
Figure 1. Specific LINE-1/c-myc and DLA Haplotype Genetic Markers for CTVT Detected by Specific PCR Amplification
(A) For each of 11 dogs (A–M), fresh normal and tumor samples are indicated as N and T, respectively. The panel is assembled from three separate
gels visualized by ethidium bromide. The invariant DLA-88 intron sequence serves as a positive control for each of the 22 specimens.
(B) PCR amplification of DNA using Cy5-labeled forward primers from 21 microdissected tumor cells from paraffin-embedded specimens. The panel
is assembled from four separate gels.paraffin-embedded specimens in addition to the fresh
tumor. Several amplicons from each tumor specimen
were sequenced because there was some variation within
tumors. Figure 3 shows that the majority of tumor mtDNA
haplotypes grouped into two clusters. Interestingly, all
tumors in mtDNA cluster 1 were homozygous diploid for
DLA DQA1, while all of those in cluster 2 except for dog
9 were haploid. This observation indicates that the ances-
tral tumor clone split into two distinguishable subclades,
each of which has become broadly distributed in many
countries.
We also used the program PAUP* (Swofford, 2003)
to estimate a maximum-likelihood tree for a subset of 21
tumor mtDNA sequences and the previously obtained
dog and wolf sequences (Figure S4). Although there is
considerable uncertainty in the tree, in part due to
substantial rate heterogeneity across sites leading to
recurrent mutations (Savolainen et al., 2002), the tumor
sequences again fall into two main clusters within canid
clade A. However, two amplicons from two of the fixed tu-
mor samples contained mtDNA unrelated to the two clus-
ters. The two outliers appear to be incompatible witha monophyletic origin of the amplified mtDNA. In these
two tumors, the microdissection may not have removed
all of the host cells because other mtDNA sequences
from the same tumors were within the clusters. We esti-
mate from histopathology (see below) that approximately
10% of cells in tumors represent host hematopoietic or
stromal cells.
Origin of CTVT
We sought to determine the genetic ancestry of CTVT by
phylogenetic alignment with previously published data
based on DLA typing (Kennedy et al., 2002b; Seddon
and Ellegren, 2002) and microsatellite analysis (Parker
et al., 2004). The DLA class II DQB1 and DQA1 alleles
that we detected in CTVT have been previously described:
DQB1 03501 was reported in North American wolves and
dogs, and DQA1 04202 was reported in huskies. The tu-
mors contained previously undescribed alleles of DLA-88
and DRB1; the two CTVT DRB1 alleles differ from each
other by only one nonsynonymous substitution and are
related to alleles 04101 of North American wolves and
04701 of Alaskan and Siberian huskies (Figure S5). TheCell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc. 479
DLA data are consistent with a tumor origin in wolves or
‘‘old’’ breeds of dog in or related to the Spitz group.
To further investigate the origin of CTVT, we genotyped
73 microsatellite loci in three tumor samples (one each
from India, Italy, and Kenya) and a subset of 18 of those
microsatellites in an additional 24 CTVT samples of di-
verse geographic origins. These microsatellites are a sub-
set of the loci genotyped by Parker et al. (2004) in a sample
of 8 wolves and 414 dogs representing 85 breeds. Analy-
sis of the dog genome (Lindblad-Toh et al., 2005) confirms
that the domestic dog (Canis familiaris) and the gray wolf
(Canis lupus) are one species. Contaminating normal al-
leles were excluded from the analysis (see Experimental
Procedures).
A model-based clustering algorithm, Structure, was
used to investigate the relationship between the CTVT
samples and the canid data (Falush et al., 2003; Pritchard
et al., 2000). This method groups individuals in a sample
into a prespecified number of clusters (K). Our initial anal-
yses applied Structure without giving it any information
about the origin of the samples (i.e., dog breed, wolf, or
CTVT; Figure S6). At K = 2, the tumor samples grouped
with the wolves and a set of dog breeds that was previ-
ously identified by Parker et al. (2004) as being genetically
most similar to wolves. At higher values of K, all of the
tumor samples clustered into a unique group that is dis-
tinct from the dogs and wolves, again indicating that the
samples have a single shared origin.
Figure 2. Microsatellite DNAAnalysis of 11 Fresh Tumors and
Matched Host Samples
Unrooted neighbor-joining tree based on chord distance compiled
from 21 microsatellite loci. A similar neighbor-joining tree based on
allele sharing is provided in Figure S2.480 Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc.To determine the specific origin of CTVT, we performed
additional Structure analyses (Figure 4A), focusing on
wolves and the subset of breeds that showed some simi-
larity to CTVT in the initial analysis. The model used al-
lowed the CTVT samples to have mixed ancestry, so
that if the progenitor animal was a mongrel dog, then the
CTVT ancestry should be spread across two or more
breeds. In this analysis, the tumor samples clustered
most strongly with wolves. A second method of analysis
applied a nonparametric clustering technique (a neigh-
bor-joining tree based on pairwise allele sharing among
genotypes) and again indicated similarity between CTVT
and the wolf samples (Figure 4B). Thus, both the model-
based method and the neighbor-joining method for micro-
satellites are consistent with our DLA analysis and indicate
that CTVT may have originated in wolves. However, some
caution is required due to the small sample sizes of each
breed and the fact that the available dog data were limited
to pedigree breeds (Parker et al., 2004), so an origin in
domestic dogs is not excluded.
Estimating the Age of CTVT
We investigated whether CTVT represents an epidemic of
a recently emerged tumor or whether it has a more ancient
origin and is in effect a stable parasite of dog populations.
The Novinski (1876) report would argue that CTVT is at
least 130 years old, assuming that the tumors he observed
were clonal with modern tumors. The tumors available to
us were collected over a period of 28 years (1976–2003)
and thus enable us to test whether CTVT has a modern
origin. Moreover, given the wide geographic distribution
of the tumor and existing knowledge of the time of diver-
gence of different dog breeds (Vila et al., 1997; Sundqvist
et al., 2006), it is possible to estimate minimum and max-
imum time limits on the emergence of the tumor clone that
is currently circulating as a cellular parasite among dogs.
We examined the level of microsatellite variation across
tumors (Figure 5). The CTVT isolates were far less variable
than wolves and dogs as a whole, and even less variable
than the most inbred (miniature bull terrier) of the 85 dog
breeds studied by Parker et al. (2004). This observation
argues strongly against an ancient date of origin for the
common ancestor of CTVT. In 17 of the 18 microsatellites
genotyped in the tumors, there is a single genotype that is
present in at least half the tumors. We assume that this
modal genotype represents that of the ancestral CTVT.
There is no trend of distance from the modal genotype
as a function of the age of our tumor samples, implying
that the common ancestor’s date of origin must be sub-
stantially older than the 28 year range of our fixed and
fresh samples.
Ignoring back mutation (which is a small effect when
most genotypes are identical), the probability that a geno-
type matches the ancestral genotype is exp(mt), where m
is the mutation rate per genotype per year and t is the time
in years since the common ancestor. Unfortunately, the
microsatellite mutation rate in CTVT is unclear. Microsatel-
lite mutation rates per allele in humans are in the range of
Figure 3. Analysis of mtDNA in CTVT
Tumor haplotypes from fresh and paraffin-embedded tissues showing two main clusters of mtDNA. Diameter of each circle is proportional to the
number of tumor samples. Each branch represents one base pair change, with black dots representing intermediates not found in the tumor samples
analyzed. The outlined boxes indicate that tumor samples with homozygous (diploid) and hemizygous (haploid) DQA1 genes coincide with mtDNA
clusters, except for tumor 9, which is diploid.103 to 104 per generation for typical loci (Huang et al.,
2002). If one assumes that genotype mutation rates per
year for CTVT are in this range, then the age estimates
range from 250 to 2500 years. If mutation rates are higher
in the tumor, as observed in some human tumors (Raptis
and Bapat, 2006), CTVT would be at the younger end of
this range.
We also computed the average expected heterozygos-
ity of the microsatellites separately for the two CTVT sub-
clades defined by diploid and haploid DQA1 alleles and by
mtDNA clusters. The subclades were only slightly less
diverse than all CTVT samples (Figure 5). This finding indi-
cates that the two major subclades split relatively soon
after the emergence of CTVT, consistent with the wide
geographic range of both subclades.
Another potential source of information about the age of
CTVT is the levels of mtDNA sequence variability within
CTVT samples and relative to dog mtDNA in general. Sa-
volainen et al. (2002) have previously estimated that the
most recent common ancestor of dog clade A lived about
41,000 years ago, assuming a star-shaped genealogy. We
found that pairwise variability of mtDNA within CTVT is
larger than the variability within dog clade A (1.38% versus
0.73% pairwise divergence), but these samples included
the two dogs with mtDNA apparently unrelated to the
two defined clusters (Figure S4). Most likely these samples
contained mtDNA from host stromal cells because, unlike
the microsatellite analysis, contaminating normal mtDNA
was not omitted. However, a possibility remains of mito-chondrial heteroplasmy within the tumor cells of some tu-
mors if CTVT became parasitized by host mitochondria
during serial passage. While the analysis of mtDNA would
suggest a much older origin, such a conclusion seems
implausible given the strikingly low microsatellite variation
observed. A high mtDNA mutation rate, together with ad-
mixture of host mtDNA or heteroplasmy in the samples,
may explain the discrepancy.
In summary, the data on microsatellite variation, includ-
ing the lack of significant accumulation of new genotypes
over the 28 years of tumor collection, and the historical
observations on transplantable CTVT since 1876 indicate
that CTVT has been transmitted among dogs for two cen-
turies or more. The microsatellite variability of CTVT is only
56% of that for the least variable dog breed (Figure 5, min-
iature bull terrier), which is probably less than 200 years old
(Parker et al., 2004; Sundqvist et al., 2006). However, since
miniature bull terriers were presumably founded by several
individuals, the most recent common ancestor of their al-
leles is probably considerably older than 200 years. These
data indicate that the tumor cannot have existed in wolves
or dogs since ancient times. Thus, the current clone of
CTVT would not appear to have been a parasite for more
than 2500 years, and probably is considerably younger.
Downregulation of MHC Expression in CTVT
The foregoing analysis shows that CTVT has been trans-
mitted as an allograft across many DLA types through in-
numerable hosts. Although dogs that have recovered fromCell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc. 481
Figure 4. Relationship of CTVT to Wolves and Dog Breeds
(A) Results of a Structure analysis of the canids that appeared most closely related to CTVT (yellow at K = 2 in Figure S6). The clustering was based on
the nontumor samples only, and the three tumor samples with nearly complete data were then assigned to the appropriate clusters.
(B) Neighbor-joining tree based on pairwise differences among the same set of individuals as in (A). The relationship between wolves and CTVT is
similar when the tree is constructed using all dogs (Figure S6).482 Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc.
Figure 5. Average Pairwise Divergence
of Microsatellite DNA in Wolves, Dogs,
and CTVT
The expected heterozygosity at microsatellite
loci in different subsets of canids and CTVT
was plotted. Non-CTVT data were derived
from Parker et al. (2004). The Australian shep-
herd represents the most diverse defined
breed and the miniature bull terrier the least
diverse breed for microsatellite DNA.CTVT are immune to tumor development upon reinocula-
tion, naive dogs of many breeds are susceptible to tumor
growth (Cohen, 1985). A recent study indicated that secre-
tion of tumor growth factor b (TGF-b1) may play a role in
local immune suppression during progressive growth but
that interleukin 6 secretion by tumor-infiltrating lympho-
cytes aids eventual immune destruction during tumor
regression (Hsiao et al., 2004). However, the expression
of MHC antigens in CTVT has not been analyzed in detail.
One study based on immunostaining indicated that b2-
microglobulin could not be detected on CTVT cells (Cohen
et al., 1984), but MHC mRNA expression has previously
not been examined.
We therefore performed RT-PCR with tumor-specific
and host-specific primers within the tumor tissue of Sicil-
ian dog C in order to investigate differential expression of
tumor and host DLA genes. Figure 6A shows that class I
expression was lower in tumor cells than in stromal cells
(which serve as a loading control) and that class II expres-
sion was absent. This result indicates significant downmo-
dulation of DLA expression in the tumor cells because theywere the majority population (90%) in the microdis-
sected tumor tissue (Figure 6B). If class I genes were
wholly unexpressed, NK cells might eliminate the tumor;
hence, our finding of low expression appears more plausi-
ble than the suggestion of defective b2-microglobulin (Co-
hen et al., 1984). A systematic and quantitative analysis
of several tumors during different phases of growth and
regression would be required to elucidate this phenome-
non more thoroughly, but that is beyond the scope of
this study. Nonetheless, our finding of DLA downregula-
tion at the transcriptional level is consistent with previous
suggestions (Cohen, 1985; Hsiao et al., 2004) that, during
progressive growth, CTVT has adapted to evade host
immune responses.
DISCUSSION
Our results, based on several independent genetic
markers in tumor-bearing dogs living on five continents,
show that CTVT arose from a common ancestral neoplas-
tic cell. Early in its evolution, the clone diverged into twoFigure 6. MHC Expression in CTVT
(A) Expression of DLA class I (DLA-88) and
class II (DRB1) in the penile tumor of dog C
by RT-PCR using tumor-cell-specific primers
(T) and primers specific to the alleles of this an-
imal for host stromal cells and infiltrating nor-
mal cells (N). M = marker lanes.
(B) Histopathology of a hematoxylin-and-
eosin-stained 4 mm section of the same tumor.
Scale bar = 30 mm. Cells with large round nuclei
are tumor cells, and mitoses are apparent. A
stromal cell is indicated with an arrow.Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc. 483
subclades, each of which now has a broad geographic
distribution. Many breeds of dog tend to be homozygous
for DLA class II genes (Kennedy et al., 2002a), and CTVT is
also homozygous for these genes when they are diploid as
in subclade 1. Our microsatellite and DLA typing indicate
that CTVT first arose in a wolf or in a dog related to the
‘‘old’’ East Asian breeds.
The precise date when CTVT first occurred is difficult to
determine. From its indistinguishable histopathology and
its ability to grow as an allograft, it is likely that Novinski
(1876) studied the same clone, and CTVT could have be-
come established centuries before this date. Our analysis
of divergence of microsatellites indicates that the tumor
arose between 200 and 2500 years ago. Whether this
time period represents the time the tumor first arose or
whether it represents a later bottleneck in the tumor’s
dispersion as a parasite cannot be resolved. While this
estimated date indicates a relatively recent evolutionary
origin, CTVT represents the oldest known mammalian so-
matic cell in continuous propagation, having undergone
countless mitoses and host-to-host transfers.
Although the tumor is highly aneuploid, the karyotype is
remarkably constant in tumors from the United States,
Kenya, and Japan (Murray et al., 1969; Oshimura et al.,
1973; Weber et al., 1965). Therefore, its genome diversity
at the chromosomal level appears to have stabilized early
in its emergence as a transmissible parasite, and our stud-
ies revealed only moderate diversification of microsatellite
DNA sequences. CTVT has active telomerase (Chu et al.,
2001), and we surmise that if telomerase activation oc-
curred after the generation of aneuploidy, the subsequent
maintenance of the remaining telomeres may have stabi-
lized the abnormal karyotype. Long-established human
tumor cell lines, such as HeLa cells, may be similar in
this regard. Other than expression of c-myc (Katzir et al.,
1987), activation of oncogenes and deletion of tumor-sup-
pressor genes have not yet been studied in CTVT.
Based on our analysis of 73 widely dispersed microsa-
tellites, there is no evidence of significant genome loss or
progressive genome instability in this longest lived of all
known tumor clones. CTVT does not appear to exhibit a
mutator phenotype (Raptis and Bapat, 2006) in terms of
microsatellite instability, and neither does it exhibit pro-
gressive chromosome instability (Brumer et al., 2006) fol-
lowing the gross rearrangements early in its emergence.
Both naturally and experimentally transplanted CTVT
exhibit an initial stage of rapid and progressive growth,
which is typically followed by spontaneous regression 3
to 9 months later, unless the dog is elderly, is in poor con-
dition, or is immunosuppressed (Cohen, 1985). After tumor
regression, the host is immune to rechallenge, and passive
transfer of serum from a recovered dog also confers immu-
nity. Experimentally, CTVT can be transplanted into immu-
nocompetent animals of other canine species, such as
foxes, coyotes, and jackals (Cohen, 1985), as well as into
immunodeficient mice (Harmelin et al., 2001; Holmes,
1981). CTVT is a histiocytic tumor (Marchal et al., 1997),
and histiocytic tumors with markers of the myeloid den-484 Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc.dritic cell lineage that express DLA class II antigens are rel-
atively frequent in dogs of several breeds (Affolter and
Moore, 2002). What has led a single clone to become
sexually transmissible as an allograft remains obscure. A
recent study (Hsiao et al., 2004) shows that, during pro-
gressive growth, secretion of TGF-b1 by CTVT acts as a
potent local inhibitor of host immune responses, as does
the downmodulation of DLA class I and II expression ob-
served by us and others (Cohen et al., 1984). Thus, the
evasion of host immune responses has enabled the tumor
to survive and grow until it can be further transmitted.
Allorecognition of nonself from self predates the evolu-
tion of the highly polymorphic MHC system and is seen in
yeast mating types, sponges, and cellular slime molds.
However, natural chimeras (Buss, 1982) do occur in meta-
zoans including colonial urochordates (Rinkevich, 2004),
and CTVT can be regarded a special case of somatic
cell chimerism. The driving selection for the evolution of
the MHC system and cell-mediated adaptive immunity in
early jawed vertebrates may have been as much to protect
against malignancy as to protect against infectious dis-
ease because invasive and metastatic tumors develop
only in vertebrates, whereas infections are universal. Al-
though recent discussion of cancer immunosurveillance
has focused on recognition within the host (Dunn et al.,
2002), the rejection of malignant allografts may have
been a factor in MHC evolution. Nonetheless, CTVT has
evolved into a cellular parasite that has gained indepen-
dence from and long outlived its original host. Since
CTVT is an asexually reproducing cell that cannot
‘‘cleanse’’ its genome of accumulated deleterious muta-
tions through recombination, it may be expected that,
over evolutionary time, its genome may suffer from slow
degradation through the process of Muller’s ratchet
(Muller, 1964). However, there is no evidence that Muller’s
ratchet has yet exerted an effect.
In humans, occult tumors in donor organs have emerged
on rare occasions in immunosuppressed transplant recip-
ients (Barozzi et al., 2003; Kauffman et al., 2002; MacKie
et al., 2003), and choriocarcinoma represents a malignant
version of the hemiallogeneic fetal trophoblast. We are not
aware of any reports on the sexual transmission of tumor
cells (for example, prostate or cervical carcinoma) be-
tween humans, but the possibility merits investigation in
transplant recipients and immunodeficient individuals
with AIDS. Cohen (1985) suggested that the emergence
of CTVT may have been favored because of the copulatory
and postcoital tie in canid species that provides a tight
contact between injured vaginal and penile mucosae for
a sufficient time to allow the implantation of tumor cells.
It is not evident from our data whether the ‘‘infective dos-
age’’ is a single cell or a bolus of tumor tissue; the latter
seems more likely from a report (Holmes, 1981) that only
13% of experimentally injected tumor cells survive to
develop into a tumor.
Given that MHC expression is downregulated in many
tumors (Khong and Restifo, 2002), it is not clear why
parasitic tumors have not emerged more frequently.
However, the natural transmissibility of CTVT does not ap-
pear to be unique. Based on karyotype, a transmissible
tumor was reported in a colony of Syrian hamsters (Cooper
et al., 1964) and can even be transmitted via mosquitoes
(Banfield et al., 1965); like CTVT, this tumor is histiocytic.
The recent emergence of a contagious tumor spread by bit-
ing in the Tasmanian devil (Pearse and Swift, 2006) also ap-
pears to represent an example of cellular transmission ac-
cording to karyotype, although a definitive analysis based
on DNA markers such as we used for CTVT is awaited.
As a sexually transmitted cell, CTVT would not have
been able to colonize dogs worldwide if it killed them
too quickly; the host must survive in a fit state long enough
to transmit the tumor, which in the case of females prob-
ably entails an estrous cycle. Thus, it will be interesting
to model the restraints preventing the emergence of
more aggressive subclones within the host and whether
epigenetic factors affect the progressive and regressive
phases of tumor growth. CTVT cells with their stabilized
genomes may reflect kinship selection and reduced viru-
lence, thus aiding host survival and onward tumor trans-
mission (Frank, 1996), whereas the evolutionary dynamics
of a ‘‘selfish,’’ dead-end tumor typically progresses to-
ward greater autonomy and malignancy (Greaves, 2002;
Michor et al., 2004).
In contrast to CTVT, the Tasmanian devil facial tumor
is highly virulent, killing most of the affected animals by
obstructing their ability to feed (Pearse and Swift, 2006).
If the devil facial tumor does not eradicate its entire host
population, it will be interesting to investigate whether
the newly emerged tumor cell lineage eventually evolves
toward a less aggressive phenotype.
In the hamster and Tasmanian devil examples, the tu-
mors spread among animals that have little genetic diver-
sity (Cooper et al., 1964; Jones et al., 2004; Owen and
Pemberton, 2006). The fact that CTVT is nearly homozy-
gous in each of the DLA class II loci and also has closely
related class I alleles may similarly have facilitated the
origin and spread of CTVT within a partially inbred popula-
tion, but today its chief reservoir is among mixed-breed
dogs, particularly strays. Thus, CTVT is not a temporary,
localized outbreak within a high-kinship group of animals;
rather, it represents the evolution of a cancer cell into a
successful parasite of worldwide distribution.
EXPERIMENTAL PROCEDURES
Tissue and DNA Sources
CTVT tissue and normal blood were obtained from dogs in different
countries; age and sex are as listed in Table S1. Canine tissue and
DNA was brought to the UK with Department for Environment, Food
and Rural Affairs permission. For histopathology to confirm diagnosis
and for microdissection, 4 mm sections were cut from paraffin-embed-
ded tumor blocks. Histological examination was performed using stan-
dard hematoxylin and eosin staining (Figure 6B). Tumor tissue was
separated from host tissue using manual microdissection under ste-
reomicroscopic observation. DNA was extracted from the microdis-
sected samples using the QIAamp DNA Micro Kit (QIAGEN). PCR
primers for the genetic loci examined are provided in Table S2.LINE-1 insertion
The LINE-1 insertion site upstream of the c-myc gene (Katzir et al.,
1987) was probed using a forward PCR primer in LINE-1 and a reverse
primer in the 30-flanking sequence (Table S2).
DLA Sequence, Gene Dosage, and Expression
To clone the DLA genes, PCR products were extracted and purified via
gel extraction kit (QIAGEN). The purified products were ligated into the
pGEM-T vector (Promega) and cloned using the TOP10 cell strain
(Invitrogen). For normal and tumor samples, 7 and 10 colonies were
randomly chosen, respectively, and the positive plasmid DNA was ex-
tracted, purified, and sequenced (Miniprep Kit, QIAGEN). In order to
determine the gene dosage of the DLA genes, real-time PCR based
on SYBR Green I fluorescence with a light cycler was used on DNA
extracted directly from tumor tissue.
For RT-PCR investigation of DLA gene expression, total RNA was
isolated from tumor and blood samples using Trizol Reagent (GIBCO),
and mRNA was isolated from total RNA using the Oligotex kit (QIA-
GEN). Single-strand cDNA was synthesized from RNA by using the Su-
perScript II RNase H-Reverse Transcriptase kit (Invitrogen). DLA-88
and DLA-DRB1 allele-specific primers and PCR conditions for CTVT
and host C are described in Table S2.
Microsatellite Genotyping
Twenty-one microsatellites were chosen for their high polymorphism in
order to test genetic differences between matched tumor and host
tissues (Figure 2). These markers are widely distributed across the
canine genome (Lindblad-Toh et al., 2005). The comparison between
tumor genotypes and host genotypes was standardized with the
same positive control sample as used by Parker et al. (2004) to align
canine genotypes for breed analysis. To investigate the breed and
date of origin of CTVT, 73 microsatellites from the loci genotyped by
Parker et al. (2004) were genotyped in three CTVT samples, one
each from India, Italy, and Kenya; a subset of 15–18 of these microsa-
tellites were genotyped in an additional 24 CTVT samples from five
continents. The primer sequences are from the Dog Genome Project
website (http://research.nhgri.nih.gov/dog_genome/). The alleles
were analyzed using GeneScan software (PE Applied Biosystems).
To determine the specific tumor genotype, any normal contaminating
alleles were excluded. In fresh specimens, normal alleles were appar-
ent from analysis of matched normal blood samples; in paraffin-
embedded specimens, the host alleles presented only minor peaks
in GeneScan because stromal cells represented no more than 10%
of the tumor sample.
Population Structure Analysis
Model-based clustering of the microsatellite data was performed using
the Structure algorithm (Falush et al., 2003; Pritchard et al., 2000),
which clusters individuals into groups. We performed separate analy-
ses both with and without using prior information about breed of origin
of DNA samples. For all analyses, the admixture model was used with
correlated allele frequencies; each run consisted of 10,000 repetitions
after 20,000 burn-in steps. Each plotted result was the run with highest
posterior probability out of five independent runs with the same param-
eters. For the analyses in Figure S6, all 27 tumor samples for which mi-
crosatellite data was available were used; for Figure 4A, only the three
tumor samples with nearly complete data were used. For Figure 4A,
the Structure option PFROMPOPFLAGONLY was used, which allowed
us to exclude the tumor samples when updating the allele frequencies
for each cluster. This forced the tumor samples to cluster with one or
more dog/wolf clusters rather than allowing the tumors to create their
own cluster. The wolf sample was larger than the breed samples (eight
individuals versus five). To check whether this biased the tumor sam-
ples to group with wolves, sets of three wolves were dropped, and the
analysis was rerun. The posterior assignment of tumors to the wolf
cluster dropped slightly (e.g., from0.74 to0.66 at K = 4). The figures
were prepared using Distruct (Rosenberg, 2004).Cell 126, 477–487, August 11, 2006 ª2006 Elsevier Inc. 485
Nonparametric Clustering of Genotypes
The neighbor-joining tree in Figure 2 was based on chord distance and
in Figure S2 on the proportion of shared alleles. The neighbor-joining
tree in Figure 4B was based on a pairwise distance matrix among all
individuals. The distance between individuals was computed as
log(p), where p is the proportion of alleles that match between two
individuals, averaged across all microsatellite loci. The plots should
be interpreted as showing nonparametric clustering of individuals
based on similarity rather than being an actual evolutionary tree, since
the loci do not come from a single linked region of the genome (Felsen-
stein, 1989).
Mitochondrial DNA Sequence and Phylogenetic Analysis
The 722 bp mtDNA control region was amplified from fresh normal and
tumor tissues as previously described (Table S2), and a 580 bp se-
quence within it was used for phylogenetic analysis (Savolainen
et al., 2002). Tumor and normal mtDNA sequences were superim-
posed on a network of published mt haplotypes (Figure S3). For paraf-
fin-embedded tumor tissues, newly designed primers for a 290 bp
fragment were used (Table S2), with 257 bp used for phylogenetic
analysis of both fresh and archival tumors (Figure 3 and Figure S4).
Between seven and ten clones from each tumor were used for DNA
sequence analysis.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, two tables, and six figures and can be
found with this article online at http://www.cell.com/cgi/content/full/
126/3/477/DC1/.
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